Welcome to Omnimabs!
TEL: 02154156726 Info: info@Omnimabs.com CN

Phospho-p16-INK4A-S140 Antibody

Catalog Number:OM217585
OM217585
Discount Price
OM217585-100ul
1~2 Week
100ul
OM217585-50ul
50ul
OM217585-20ul
20ul
1~2 Week
Product Profile
Product Name Phospho-p16-INK4A-S140 Antibody
Antibody Type Primary Antibodies
Antigen Alias CDKN2A; CDKN2; MTS1; Cyclin-dependent kinase inhibitor 2A, isoforms 1/2/3; Cyclin-dependent kinase 4 inhibitor A; Multiple tumor suppressor 1; p16-INK4a
Modification p-S140
Key Feature
Clonality Polyclonal
Isotype Ig
Host Species Rabbit
Tested Applications WBIHC
WB:1:100~500 IHC
Species Reactivity Human
Concentration 1mg/ml
Target Information
Gene Synonyms CDKN2
MTS1
Alternative Names CDKN2A
CDKN2
MTS1
Cyclin-dependent kinase inhibitor 2A
isoforms 1/2/3
Cyclin-dependent kinase 4 inhibitor A
Multiple tumor suppressor 1
p16-INK4a
Molecular Weight(MW) 16533 Da
Function Acts as a negative regulator of the proliferation of normal cells by interacting strongly with CDK4 and CDK6. This inhibits their ability to interact with cyclins D and to phosphorylate the retinoblastoma protein
Tissue Specificity Widely expressed but not detected in brain or skeletal muscle. Isoform 3 is pancreas-specific
Cellular Localization Cytoplasm. Nucleus.
Database Links
Entrez Gene 1029
Application

Application

The anti-Phospho-p16-INK4A-S140 Pab is used in Western blot to detect Phospho-p16-INK4A-S140 in A2058 tissue lysate

Application

Formalin-fixed and paraffin-embedded human cancer tissue reacted with the primary antibody, which was peroxidase-conjugated to the secondary antibody, followed by DAB staining. This data demonstrates the use of this antibody for immunohistochemistry; clinical relevance has not been evaluated. BC = breast carcinoma; HC = hepatocarcinoma.
Application Notes WB:1:100~500 IHC
Additional Information
Form Liquid
Storage Instructions For short-term storage, store at 4° C. For long-term storage, aliquot and store at -20ºC or below. Avoid multiple freeze-thaw cycles.
Storage Buffer Purified polyclonal antibody supplied in PBS with 0.09% (W/V) sodium azide. This antibody is first purified by protein G affinity chromatography. Then, the antibody fraction is peptide affinity purified in a 2-step procedure with control and phosphorylated peptides. The phospho-specific antibody is eluted with high and low pH buffers and neutralized immediately, followed by dialysis against PBS.
validation
question title
question detaiil
Verification code